Latest Plasmodium vivax Stories
A new evidence-based global distribution map of Plasmodium vivax malaria, published August 3 in the open-access journal PLoS Neglected Tropical Diseases, is used to estimate that 2.85 billion people lived at risk of infection with this parasite in 2009.
ROCKVILLE, Md., April 19 /PRNewswire/ -- Protein Potential LLC has received support from the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH in the form of a Phase II Small Business Innovation Research (SBIR) Grant.
Study proves blood-stage infection due to population mixing and disease evolution
A U.S.-led team of scientists has identified the complete genetic sequence of a parasite that is the leading cause of relapsing malaria. Working at The Institute for Genomic Research/J. Craig Venter Institute in Rockville, Md., the scientists studied the parasite Plasmodium vivax.
By Cooper, R G Magwere, T Chloroquine (CHQ) is a cheap, relatively well tolerated drug initially developed for the treatment of malaria in the 1930s.
By specially tagging the outer and inner membranes of red blood cells infected with the malaria parasite and tracking the cellular changes that precede the cell bursting event that disperses parasites to other blood cells, a group of researchers has deepened our understanding of how the malaria pathogen destroys the cells in which it resides. The work is reported in Current Biology by Joshua Zimmerberg and colleagues at the U.S. National Institutes of Health.
- A volcanic mudflow.